Dashenlin Pharm Grp Co Ltd (603233) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.096x

Based on the latest financial reports, Dashenlin Pharm Grp Co Ltd (603233) has a cash flow conversion efficiency ratio of 0.096x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥818.72 Million ≈ $119.80 Million USD) by net assets (CN¥8.49 Billion ≈ $1.24 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Dashenlin Pharm Grp Co Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Dashenlin Pharm Grp Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Dashenlin Pharm Grp Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Dashenlin Pharm Grp Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dashenlin Pharm Grp Co Ltd ranked by their cash flow conversion efficiency. Explore 603233 cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Kemira Oyj HE:KEMIRA	0.075x
SKC Co. Ltd KO:011790	-0.074x
Green Brick Partners Inc NYSE:GRBK	-0.006x
Solvay SA BR:SOLB	0.144x
Sportradar Group AG NASDAQ:SRAD	0.150x
Fortior Technology (Shenzhen) Co. Ltd. A SHG:688279	N/A
Jumbo S.A. AT:BELA	0.023x
Provident Financial Services Inc NYSE:PFS	0.041x

Annual Cash Flow Conversion Efficiency for Dashenlin Pharm Grp Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Dashenlin Pharm Grp Co Ltd from 2012 to 2025. View Dashenlin Pharm Grp Co Ltd stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥8.66 Billion ≈ $1.27 Billion	CN¥5.35 Billion ≈ $782.90 Million	0.618x	+61.83%
2024-12-31	CN¥8.14 Billion ≈ $1.19 Billion	CN¥3.11 Billion ≈ $454.55 Million	0.382x	-4.60%
2023-12-31	CN¥7.93 Billion ≈ $1.16 Billion	CN¥3.17 Billion ≈ $464.43 Million	0.400x	-26.90%
2022-12-31	CN¥6.86 Billion ≈ $1.00 Billion	CN¥3.76 Billion ≈ $549.70 Million	0.547x	+108.91%
2021-12-31	CN¥5.94 Billion ≈ $868.61 Million	CN¥1.55 Billion ≈ $227.54 Million	0.262x	-25.28%
2020-12-31	CN¥5.57 Billion ≈ $815.49 Million	CN¥1.95 Billion ≈ $285.92 Million	0.351x	-11.07%
2019-12-31	CN¥4.33 Billion ≈ $633.86 Million	CN¥1.71 Billion ≈ $249.90 Million	0.394x	+39.29%
2018-12-31	CN¥3.09 Billion ≈ $451.68 Million	CN¥873.64 Million ≈ $127.84 Million	0.283x	+23.87%
2017-12-31	CN¥2.80 Billion ≈ $410.12 Million	CN¥640.39 Million ≈ $93.71 Million	0.228x	-38.12%
2016-12-31	CN¥1.34 Billion ≈ $196.39 Million	CN¥495.60 Million ≈ $72.52 Million	0.369x	-19.52%
2015-12-31	CN¥1.02 Billion ≈ $149.43 Million	CN¥468.59 Million ≈ $68.57 Million	0.459x	-41.20%
2014-12-31	CN¥574.85 Million ≈ $84.12 Million	CN¥448.58 Million ≈ $65.64 Million	0.780x	+59.72%
2013-12-31	CN¥589.93 Million ≈ $86.32 Million	CN¥288.22 Million ≈ $42.18 Million	0.489x	-35.64%
2012-12-31	CN¥381.11 Million ≈ $55.77 Million	CN¥289.31 Million ≈ $42.34 Million	0.759x	--

About Dashenlin Pharm Grp Co Ltd

SHG:603233 China Pharmaceutical Retailers

Market Cap

$2.96 Billion

CN¥20.21 Billion CNY

Market Cap Rank

#5008 Global

#868 in China

Share Price

CN¥17.75

Change (1 day)

-1.11%

52-Week Range

CN¥14.80 - CN¥21.27

All Time High

CN¥57.53